US Dept of Labor

Occupational Safety & Health AdministrationWe Can Help

References


Human studies
  • 1,3-Butadiene. Department of Health and Human Services (DHHS), National Institute for Occupational Safety and Health (NIOSH) Current Intelligence Bulletin 41, Publication No. 84-105, (1984).
  • 1,3-Butadiene: inhalation teratogenicity in the rat (final report with cover letter dated 08/11/82). International Institute of Synthetic Rubber Producers (IISRP) (1082). Report no. 2788-522/3; submission 8EHQ-0382-0441. Harrowgate, England: Hazleton Laboratories Europe, Ltd.
  • Downs, T., S. Pier, and M. Crane. "Cause-specific mortality in a cohort of 1,000 ABS workers." Abstr Symp. Butadiene and styrene: assessment of health hazards. (1992). Espoo, Finland.
  • Matanoski, G.M., et al. "Epidemiologic data related to health effects of 1,3-Butadiene. In: Assessment of inhalation hazards." Mohr, U; Bates, DV; Dungworth, DL; et al (1989). eds. New York, NY: Springer-Verlag, 201-214.
  • Delzell, E., N. Sathiakumar, and M. Macaluso. "A follow-up study of synthetic rubber workers." (1995). Final report prepared under contract to International Institute of Synthetic Rubber Producers.
  • Matanoshi, G.M., et al. "Mortality of Workers in the Styrene-butadiene Rubber Polymer Manufacturing Industry." (1982).A Report Prepared under Contract to the International Institute of Synthetic Rubber Producers.
  • American Journal of Epidemiology
    • Monson, R.R. and K.K. Nakano. "Mortality among rubber workers. I. White male union employees in Akron, Ohio." 103(1976): 284-296.
    • Beaumon, J.J. and N.E. Breslow. "Power considerations in epidemiologic studies of vinyl chloride workers." 114(1981):725-734.
  • Downs, T.D., M.M. Crane, and K.W. Kim. "Mortality among workers at a butadiene facility." (1987). Am J Ind Med 12:311-329.
  • Duescher, R.J. and A.A. Elfarra. "Human liver microsomes are efficient catalysts for 1,3-Butadiene oxidation: evidence for major roles by cytochrome P450 2A6 and 2E1." Archives of Biochemistry and Biophysics 311(1994):342-349.
  • Malvoisin, E., M. Mercier, and M. Roberfroid. "Enzymatic hydration of butadiene monoxide and its importance in the metabolism of butadiene." Biol Reactive Intermed II, 136A(1981):437-444.
  • Carcinogenesis
    • Cochrane, J.E. and T.R. Skopek. "Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts." 15(1994): 713-717.
    • Melnick, R.L. and M.C. Kohn. "Mechanistic data indicate that 1,3-butadiene is a human carcinogen." (1995). 16(1995): 157-163.
  • Maniglier-Poulet, C., et al. "Metabolism of 1,3-butadiene to butadiene monoxide in mouse and human bone marrow cells." Chemico-Biological Interactions 97(1995):119-129.
  • Environmental Health Perspectives
    • Melnick, R.L., et al. "Symposium overview: toxicology, carcinogenesis, and human health aspects of 1,3-butadiene." 86(1990): 3-5.
    • Divine, B.J. "An update on mortality among workers at a 1,3-butadiene facility – preliminary results." 86(1990): 119-128.
    • Irons, R.D. "Studies on the mechanism of 1,3-butadiene-induced leukemogenesis: the potential role of endogenous murine leukemia virus." 86(1990): 49-55.
    • Ward, J.B., et al. "hprt Mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant." 1.2(1994):79-85.
    • Ward, E.M., J.M. Fajen, and A. Ruder, A. "Mortality study of workers in 1,3-butadiene production units identified from a chemical workers cohort." 103(1995):598-603.
    • Ward, J.B., Jr, et al. "hprt Mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant." 102(1994): 79-85.
    • Matanoski, G.M., C. Santos-Burgoa, and L. Schwartz "Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943-1982)."86(1990): 107-117.
    • Morrow, N.L. "The industrial production and use of 1,3-butadiene." 86(1990):7-8.
  • Ward, J.B., Jr, M.M. Ammenheuser, and W.E. Bechtold. "Assessment of butadiene exposure in a rubber plant using urine metabolite and HPRT mutant frequency as biological markers of exposure and effect." (Abstract) Environmental and Molecular Mutagenesis 27(1996a):73.
  • Acquavella, JF. "The paradox of butadiene epidemiology." Experimental Pathology 37(1989):114.
  • International Agency for Research on Cancer (IARC)
    • IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. (1982). Vol. 28. The rubber industry. Lyon, France: International Agency for Research on Cancer.
    • IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Vol. 39. Some chemicals used in plastics and elastomers butadiene. (1986). Lyon, France: International Agency for Research on Cancer, 155-179.
    • IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 54. 1,3-Butadiene. Occupational exposures to mists and vapours from strong inorganic acids and other industrial chemicals. (1992). Lyon, France: International Agency for Research on Cancer, 237-287.
    • "Mutagenicity of 1,3-butadiene and its epoxide metabolites in human TK6 cells and splenic T cells isolated from exposed B6C3F1 mice." In: Butadiene and styrene: assessment of health hazards. Cochrane, J.E.; Skopek, T.R. (1993). IARC Scientific Publications. Vol. 127;. Sorsa, M.; Peltonen, K.; Vainio, H.; et al, eds. Lyon, France: International Agency for Research on Cancer, 195-204.
  • Bulbulyan, M.A. et al. "Cancer incidence and mortality in a cohort of chloroprene workers from Armenia." International Journal on Cancer 81.1(1999): 31-33.
  • Duescher, R.J., and A.A. Elfarra. "1,3-Butadiene oxidation by human myeloperoxidase: role of chloride ion in catalysis of divergent pathways."Journal of Biological Chemistry 267(1992): 19859.
  • Carpenter, C.P., et al. "Studies on the inhalation of 1,3-butadiene; with a comparison of its narcotic effect with benzol, toluol and styrene, and a note on the elimination of styrene by the human." J Ind Hyg Toxicol. 26(1944): 69-78.
  • J. Occup. Med.
    • McMichael, A.J., et al. "Mortality among Rubber Workers: Relationship to Specific Job."18(1976): 178-185.
    • Matanoski, G.M. and L. Schwartz. "Mortality of workers in styrene-butadiene polymer production." 29(1987): 675-680.
  • Osterman-Golkar, S.M., et al. "Haemoglobin adducts as biomarkers of occupational exposure to 1,3-butadiene." Mutagenesis 11(1996): 145-149.
  • Kelsey, K.T., et al. "Sister-chromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutation Research/Environmental Mutagenesis and Related Subjects 335(1995): 267-273.
  • Andjelkovich, D., J. Taulbee, and M.J. Symons. "Mortality Experiences of a Cohort of Rubber Workers 1964-1973." Occup. Med. 18(1976): 387-394.
  • Cowles, S.R., et al. "Mortality, morbidity, and haematologic results from a cohort of long-term workers involved in 1,3-butadiene monomer production." Occupational and Environmental Medicine 51(1994): 323-329.
  • Meimhardt, T.J., et al. "Environmental Epidemiologic Investigations of the Styrene-butadiene Rubber Industry. Mortality Patterns with Discussion of Hematopoietic and Lymphatic Malignancies." Scandinavian Journal of Work, Environment, and Health 8:250-259.
  • Scientific Publications
    • Matanoski, G.M., M. Francis, and A. Correa-Villasenor. "Cancer epidemiology among styrene-butadiene rubber workers. In: Butadiene and styrene: assessment of health hazards." Scientific Publications. 127(1993). Sorsa, M.; Peltonen, K.; Vainio, H.; et al, eds. Lyon, France: International Agency for Research on Cancer.
    • Divine, B.J., J.K. Wendt, and C.M. Hartman. "Cancer mortality among workers at a butadiene facility. In: Butadiene and styrene: assessment of health hazards." (1993). IARC Scientific Publications 127(1993): 345-362. Sorsa, M.; Peltonen, K.; Vainio, H.; et al, eds. Lyon, France: International Agency for Research on Cancer.
  • Toxicology
    • Sorsa, M., et al. "Assessment of exposure to butadiene in the process industry." (1996). 113(1996): 77-83.
    • Tates, A.D., et al. "Biological effect monitoring in industrial workers from the Czech Republic exposed to low levels of butadiene." 113(1996): 91-99.
    • Ward, J.B., Jr., et al. "Biological monitoring for mutagenic effects of occupational exposure to butadiene." 113(1995): 84-90.
    • Delzell, E., N. Sathiakumar, and M. Hovinga. "A follow-up study of synthetic rubber workers. 113(1996): 182-189.
    • Macaluso, M.; R. Larson, and E. Delzell. "Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry." 113(1996): 190-202.
    • Divine, B.J. and C.M. Hartman. "Mortality update of butadiene production workers." 113(1996): 169-181.
    • Ward, E.M., J.M. Fajen, and A. Ruder. "Mortality study of workers employed in 1,3-butadiene production units identified from a large chemical workers cohort." 113(1996): 157-168.
    • Hayes, R.B., et al "hprt Mutation frequency among workers exposed to 1,3-butadiene in China." 113(1996): 100-105.
Animal Studies
  • 1,3-Butadiene: inhalation teratogenicity study in the rat (final report). Hazleton Laboratories Europe, Ltd. (HLE). Harrowgate, England: Hazleton Labs; addendum no. 2788-522/3. (1981).
  • The detection of dominant lethal mutations and foetal malformations, tumours and chromosome damage in the offspring of male mice treated sub-chronically with butadiene. Anderson, D.; Edwards, A.J.; Brinkworth, M.H. (1995). BIBRA Report No. 1060/5/95.
  • Dominant lethal study in CD-1 mice following inhalation exposure to 1,3-butadiene (final technical report). Hackett, P.L.; McClanahan, B.J.; Mast, T.J.; et al (1988b). Richland, WA: Pacific Northwest Laboratory; PNL no. PNL-6545 UC-408; NIH no. NIH-Y01-ES-70153; 85 p. Prepared for NIEHS, NTP, under a Related Services Agreement with the U.S. Department of Energy under contract DE-AC06-76RLO-1830.
  • The in vivo mutagenic potential of 1,3-butadiene, evaluated at the hprt locus of T-cells, is greater in mice than in rats exposed concurrently by inhalation. Meng, Q.; Recio, L.; Reilly, A.A.; et al (1996). Abstract presented at the Twelfth Health Effects Institute Annual Conference.
  • Inhalation developmental toxicology studies of 1,3-butadiene in the rat (final report). Hackett, P.L.; Sikov, M.R.; Mast, T.J.; et al (1987a) Richland, WA: Pacific Northwest Laboratory; PNL Report No. PNL-6414 UC-48; NIH Report No. NIH-401-ES-41031; 104 p. Prepared for NIEHS, NTP, under a Related Services Agreement with the US Department of Energy under contract DE-AC06-76RLO-1830.
  • Inhalation developmental toxicology studies: teratology study of 1,3-butadiene in mice (final report). Hackett, P.L.; Sikov, M.R.; Mast, T.J.; et al (1987b) Richland, WA: Pacific Northwest Laboratory; PNL Report No. PNL-6412 UC-48; NIH Report No. NIH-401-ES-40131; 92 p. Prepared for NIEHS, NTP, under a Related Services Agreement with the US Department of Energy under contract DE-AC06-76RLO-1830.
  • A quantitative assessment of the risk of cancer associated with exposure to 1,3-butadiene, based on a low dose inhalation study in B6C3F1 mice. National Institute for Occupational Safety and Health (NIOSH) (1991a). Submitted to the Occupational Safety and Health Administration (OSHA) for Butadiene Docket (#H-041). US Department of Health and Human Services, Washington, DC.
  • Sperm-head morphology study in B6C3F1 mice following inhalation exposure to 1,3-butadiene (final technical report). Hackett, P.L.; McClanahan, B.J.; Brown, M.G.; et al (1988a). Richland, WA: Pacific Northwest Laboratory; PNL Report No. PNL-6459 UC-48; NIH Report No. NIH-Y01-ES-70153; 51 p. Prepared for NIEHS, NTP, under a Related Services Agreement with the US Department of Energy under contract DE-AC06-76RLO-1830.
  • Toxicological profile for 1,3 butadiene. TP-91/ 07, PB93-11690. Agency for Toxic Substances and Disease Registry (ATSDR). Public Health Service, US Department of Health and Human Services, Atlanta, GA (1992).
  • Toxicology and carcinogenesis studies of 1,3-butadiene (CAS No. 106-99-0) in B6C3F1 mice (inhalation studies). National Toxicology Program (NTP), U.S. Public Health Service, US Department of Health and Human Services (1993). NTP TR 434. Research Triangle Park, NC.
  • Elfarra, A.A., R.J. Duescher, R.J., and C.M. Pasch. "Mechanisms of 1,3-butadiene oxidations to butadiene monoxide and crotonaldehyde by mouse liver microsomes and chloroperoxidase." Archives of Biochemistry and Biophysics 286(1991): 244-251.
  • Laib, R.J., et al. "Pharmacokinetic interaction between 1,3-butadiene and styrene in Sprague-Dawley rats." Arch Toxicol 66(1992): 310-314.
  • Melnick, R.L., et al. "Isoprene, an endogenous hydrocarbon and industrial chemical, induces multiple organ neoplasia in rodents after 26 weeks of inhalation exposure." Cancer Res 54(1994): 5333-5339.
  • Carcinogenesis
    • Thornton-Manning, J.R., et al. "Gender differences in the metabolism of 1,3- butadiene in Sprague-Dawley rats following low-level inhalation exposure." 16(1995): 2875-2878.
    • Medinsky, M.A., et al. "In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data." 15(1994):1329-1340.
    • Himmelstein, M.W., et al. "Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation." 15(1994): 1479-1486.
    • Thornton-Manning, J.R., et al. "Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene." 16(1995): 1723-1731.
    • Cochrane, J.E. and T.R. Skopek. "Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene, and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice." 15(1994): 719-723.
  • Chemical Research in Toxicology
    • Nauhaus, S.K., et al. "Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-C-13] butadiene." 9(1996): 764-773.
    • Elfarra, A.A., J.E. Sharer, and R. J. Duescher. "Synthesis and characterization of N-acetyl-L-cysteine S-conjugates of butadiene monoxide and their detection and quantitation in urine of rats and mice given butadiene monoxide." 8(1995): 68-76.
    • Oe T.; et al. "Persistence of N7-(2,3,4-trihydroxybutyl)guanine adducts in the livers of mice and rats exposed to 1,3-butadiene." 12.3(1999): 247-257.
    • Richardson K.A., et al. "Identification of novel metabolites of butadiene monoepoxide in rats and mice." 11.12(1998): 1543-1555.
  • Sharer, J.E., R.J. Duescher, and A.A. Elfarra. "Species and tissue differences in the microsomal oxidation of 1,3- butadiene and the glutathione conjugation of butadiene monoxide in mice and rats." Drug Metab Dispos 20(1992):658- 664.
  • Environmental Health Perspectives
    • Laib, R.J., et al. "Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice." 86(1990): 57-63.
    • Melnick, R.L., et al. "Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure." 86(1990c): 27-36.
    • Evelo, C.T.A., et al. "Physiologically based toxicokinetic modeling of 1,3- butadiene lung metabolism in mice becomes more important at low doses." (1993). 101(1993):496-502.
  • Anderson, D., A.J. Edwards, A.J.; Brinkworth, M.H. "Male-mediated F1 effects in mice exposed to 1,3-butadiene. In: Butadiene and styrene: assessment of health hazards." (1993). IARC Scientific Publications. Vol. 127. Sorsa, M.; Peltonen, K.; Vainio, H.; et al, eds. Lyon, France: International Agency for Research on Cancer, 171-181.
  • 1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8,000 parts per million. In: Butadiene and styrene: assessment of health hazards. Melnick, R.L.; Huff, J.E. (1993). IARC Scientific.
  • Bolt, H.M., et al. "Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats." J Cancer Res Clin Oncol. 106(1983): 112-116.
  • Mutation Research
    • Adler, I.D., et al. "Heritable translocations induced by inhalation exposure of male mice to 1,3-butadiene." 347(1995): 121-127.
    • Adler, I.D. and D. Anderson. "Dominant lethal effects after inhalation exposure to 1,3-butadiene." 309(1994): 295-297.
    • Adler, I.D., et al. "Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice. 309(1994): 307-314.
    • Kligerman A.D.; et al. "Comparison of cytogenetic effects of 3,4-epoxy-1-butene and 1,2:3, 4-diepoxybutane in mouse, rat and human lymphocytes following in vitro G0 exposures." 439.1(1999): 13-23.
  • Filser, J.G., et al. "Metabolism of 1,3-butadiene in microsomes from livers of mouse, rat, and man." Naunyn-Schmiedeberg's Arch Toxicol Suppl. 345.R31(1992).
  • Toxicology and Applied Pharmacology
    • Dahl, A.R., et al. "The fate of isoprene inhaled by rats: comparison to butadiene." 89(1987): 237-242.
    • Himmelstein, M.W., B. Asgharian, and J.A. Bond. "High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene." 132(1995): 281-288.
    • Irons, R.D., et al. "Macrocytic-megaloblastic anemia in male NIH Swiss mice following repeated exposure to 1,3-butadiene. 85(1986): 450-455.
    • Dahl, A.R., et al. "Toxicokinetics of inhaled 1,3-butadiene in monkeys: comparison to toxicokinetics in rats and mice." 110(1991): 9-19.
    • Irons, R.D., et al. "Susceptibility to 1,3-butadiene-induced leukemogenesis correlates with endogenous ecotropic retroviral background in the mouse." 101(1989): 170-176.
  • Toxicology Letters
    • Deutschmann, S. and R.J. Laib. "Concentration-dependent depletion of non-protein sulfhydryl (NPSH) content in lung, heart and liver tissue of rats and mice after acute inhalation exposure to butadiene." 45(1989):175-183.
    • Kreiling, R., R.J. Laib, and H.M. Bolt. "Depletion of hepatic non-protein sulfhydryl content during exposure of rats and mice to butadiene." 41(1988): 209-214.
    • Recio, L. and T.L. Goldsworthy. "The use of transgenic mice for studying mutagenicity induced by 1,3- butadiene." 82(1995): 607-612.
  • Thornton-Manning, J.R., et al. "Tissue concentrations of butadiene epoxides in rodents following multiple and single exposures to 1,3-butadiene (BD) by inhalation." Toxicologist 30(1996):215.
  • Toxicology
    • Dunnick, J.K., et al. "Respiratory tract lesions in F344/N rats and B6C3F1 mice after inhalation exposure to 1,2-epoxybutane." 50(1988): 69-82.
    • Doerr, J.K., E.A. Hollis, and I.G. Sipes. "Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats." 113(1996): 128-136.
  • Irons, R.D., W.S. Stillman, M.W. Cloyd. "Selective activation of endogenous ecotropic retrovirus in hematopoietic tissues of B6C3F1 mice during the preleukemic phase of 1,3-butadiene exposure." Virology 161(1987): 457- 462.
Other
  • Locating and estimating air emissions from sources of 1,3- butadiene. Environmental Protection Agency (EPA), Office of Air Quality Planning and Standards, (1994a).
  • Memo from Rich Cook, Office of Mobile Sources to Dennis Beauregard. Environmental Protection Agency (EPA), Office of Air Quality Planning and Standards, (1994b) (November 9, 1994).
  • Occupational exposure to 1,3-butadiene; final rule. Occupational Safety and Health Administration (OSHA), (1996, November 4). Federal Register 61(214):56745-56795.
  • Occupational exposure to 1,3-butadiene; proposed rule and notice of hearing. Occupational Safety and Health Administration (OSHA), (1990, August 10). Federal Register 55:32736-32776.
  • Pharmacokinetic/mechanism-based analysis of the carcinogenic risk of butadiene. PB88-20817. Hattis, D.; Wasson, J.,(1987). Rockville, MD: National Institute for Occupational Safety and Health, 1-122.
  • Proposed identification of 1,3-butadiene as a toxic air contaminant. California Air Resources Board, (1991). Prepared by the Office of Environmental Health Hazard Assessment. Sacramento, CA.
  • Proposed identification of 1,3-butadiene as a toxic air contaminant. Part A. Exposure assessment. California Air Resources Board. Stationary Source Division, Sacramento, CA, (1992).
  • Proposed guidelines for carcinogen risk assessment. Environmental Protection Agency (EPA), (1996, April 23). Federal Register 61(79):17960-18011.
  • Review of sources and emission estimates for 1,3-butadiene. Ligocki, M.P., (1993). SYSAPP-93/074. Prepared by Systems Applications International, Inc., San Rafael, CA.
  • A survey of exposures to gasoline vapour. Report No. 4/87. Concawe, (1987). de Hague: Concawe.
  • Toxicological profile for 1,3-butadiene. Department of Health and Human Services (DHHS), Public Health Service, (1992).
  • The use of the benchmark-dose approach in health risk assessment. Environmental Protection Agency (EPA), Office of Research and Development, EPA/630/R-94/007, (1995).
  • American Industrial Hygiene Association Journal
    • Bond, J.A., et al. "Species differences in the distribution of butadiene in tissues." 48(1987): 867-872.
    • Checkoway, H. and T.M. Williams. "A hematology survey of workers at a styrene-butadiene synthetic rubber manufacturing plant." 4.3(1982): 164-169.
  • Jelitto, B., R.R. Vangala, and R.J. Laib. "Species differences in DNA damage by butadiene: role of diepoxybutane. Archives of Toxicology 13(1989): 246-249.
  • Hallenbeck, W. "Cancer risk assessment for the inhalation of 1,3-butadiene using physiologically based pharmacokinetic modelling." Bulletin of Environment Contamination and Toxicology 49(1992):66-70.
  • Goodrow, T., et al. "Activation of K-ras by codon 13 mutations in C57BL/6 × C3HF1 mouse tumors induced by exposure to 1,3-butadiene." Cancer Res 50(1990): 4818-4823.
  • Carcinogenesis
    • Brunnemann, K.D., et al. "Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection." 11(1990): 1863.
    • Kohn, M.C. and R.L. Melnick. " Species differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, control. 14(1993):619-628.
  • Bechtold, W.E., et al. "Analysis of butadiene, butadiene monoxide and butadiene diepoxide in blood by gas chromatography/gas chromatography/mass spectroscopy." Chemical Research in Toxicology 8(1995): 182-187.
  • Anon. "Chemical profile: butadiene." Chem Mark Rep 239(1991): 50.
  • Csanády, G.A. and J.A. Bond. "Species differences in the biotransformation of 1,3-butadiene to DNA-reactive epoxides: role in cancer risk assessment. Chemical Industry Institute of Toxicology, CIIT Activities 11(1991): 1-8.
  • Himmelstein, M.W., et al. "Toxicology and epidemiology of 1,3-butadiene." Crit Rev Toxicol, 27.1(1997):1-108.
  • Cole, P., E. Delzell, and J. Acquavella. "Exposure to butadiene and lymphatic and hematopoietic cancer." Epidemiology 4(1993):86.
  • Dahl, A.R., et al. "Species differences in the metabolism and disposition of inhaled 1,3-butadiene and isoprene." Environmental Health Perspectives 86(1990):65-69.
  • Rosenthal, S.L. "The reproductive effects assessment group's report on the mutagenicity of 1,3-butadiene and its reactive metabolites." Environ Mutagen 7(1985): 933-945.
  • Crump, K.S. "A new method for determining allowable daily intakes." Fundam Appl Toxicol 4(1984): 854-871.
  • Norppa, H. and M. Sorsa. "Genetic toxicology of 1,3-butadiene and styrene. In: Butadiene and styrene: assessment of health hazards." (1993). IARC Scientific Publications. Vol. 127. Sorsa, M.; Peltonen, K.; Vainio, H.; et al, eds. Lyon, France: International Agency for Research on Cancer, 185-193.
  • Nordlinder, R.G., R.I. Nilsson, and A.B. Buskhe. "1,3-butadiene in gasoline: an analytical conclusion." J Occup Environ Med. 38(1996):463.
  • Andjelkovich, D., J. Taulbee, and M. Symons. "Mortality of rubber workers with reference to work experience." J Occup Med 19(1997): 397-405.
  • Mutat Res
    • De Meester, C. "Genotoxic properties of 1,3-butadiene." 195(1988): 273-281.
    • Jacobson-Kram, D. and S. Rosenthal. "Molecular and genetic toxicology of 1,3-butadiene." 339(1995): 121- 130.
  • Andjelkovich, D., J. Taulbee, and M.J. Symons. "Mortality experience of a cohort of rubber workers, 1964-1973." Occup Med 18(1976):387-394.
  • Bond, J.A. and G.A. Csanády. "Species and organ differences in the in vitro metabolism of butadiene to butadiene monoepoxide." Proc Am Assoc Cancer Res 32(1991): 119.
  • Toxicology and Applied Pharmacology
    • Bond, J.A., et al. "Species differences in the disposition of inhaled butadiene." 84(1986): 617-627.
    • Bechtold, W.E., et al. "Species differences in urinary metabolite ratios between mice, rats, and humans." 127(1994): 44-49.
Back to Top

Thank You for Visiting Our Website

You are exiting the Department of Labor's Web server.

The Department of Labor does not endorse, takes no responsibility for, and exercises no control over the linked organization or its views, or contents, nor does it vouch for the accuracy or accessibility of the information contained on the destination server. The Department of Labor also cannot authorize the use of copyrighted materials contained in linked Web sites. Users must request such authorization from the sponsor of the linked Web site. Thank you for visiting our site. Please click the button below to continue.

Close